|
Sovilnesib Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- Volastra Therapeutics, Inc.1
Indications
- Primary Peritoneal Carcinoma1
- Chromosomal Instability1
- High Grade Serous Adenocarcinoma of Ovary1
- Fallopian Tube Cancer1
- Cancer1
Birmingham, Alabama1 trial
A Study of Sovilnesib in Subjects With Ovarian Cancer
The University of Alabama at Birmingham
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.